By Monica Heger
This story was originally published Oct. 17.
Sequenom said this week that it has launched its noninvasive lab-developed sequencing-based test for Down syndrome in 20 US metropolitan areas and has published a clinical validation study for the test in the journal Genetics in Medicine.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Nature this week: weighting scheme increases GWAS power, and more.
Marc Tessier-Lavigne is to be the next president of Stanford University.
Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.
Journals and research funding agencies pledge to enable the sharing of Zika virus research.
This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.
This webinar will discuss Qiagen's approach to address two challenges facing NGS in the clinical research setting: lack of seamless workflow for routine clinical research use and truly relevant content to guide clinical research activities.